In its ruling in Mayo Collaborative Services v. Prometheus Laboratories, Inc., the Supreme Court unanimously reversed the Federal Circuit’s decision, stating that the diagnostic tests for determining the appropriate dosage of medication employed by Prometheus were not patentable because they “effectively claim the underlying laws of nature themselves.” In issuing its ruling, The Supreme Court [...]
